Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma

To evaluate the National Comprehensive Cancer Network (NCCN) International Prognostic Index (IPI), we analyzed 284 patients treated with the combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in our institution in Japan. Their 5-year overall survival (OS) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950647/
https://www.ncbi.nlm.nih.gov/pubmed/27489766
http://dx.doi.org/10.1016/j.lrr.2016.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950647/
https://www.ncbi.nlm.nih.gov/pubmed/27489766
http://dx.doi.org/10.1016/j.lrr.2016.06.003

Ejemplares similares